European Archives - Page 358 of 1101 - European Medical Journal

Improving first-line therapy of Patients with Rheumatoid arthritis with optimised Methotrexate

Delve into the latest advancements and offer perspectives in the management of rheumatoid arthritis with a specific focus on optimising methotrexate.

Exercise Improves Lung Function in Adults with Asthma

Participation in exercise programmes has brought about improvement in the lung function of adults with asthma…

Does Age Influence Paediatric COVID-19 Severity?

Assessment of paediatric COVID-19 disease severity should include consideration of the age of the child, according to new research findings from a multicentre retrospective cohort study.

Editor’s Pick: Assessing the Relationship Between Vitiligo and Cardiovascular Disease Risk Factors

Vitiligo is an autoimmune disorder characterised by the loss of melanocytes, resulting in white, depigmented cutaneous macules…

Global Perspectives in Non-Operative Osteoarthritis (OA) Treatment

The increase in demand for non-operative OA care continues to grow, as healthcare professionals and their patients look for safe…

Spoonful of technology: September 2023

Learn about the top healthcare technology stories of the past few months, highlighting four innovative examples of how companies are harnessing artificial intelligence to benefit key stakeholders.

Malaria: Increase in Partial Artemisinin Resistance in Uganda

New research has raised concerns that Plasmodium falciparum partial resistance to artemisinin is increasing in Uganda…

Meet the Expert Session: Skincare, Ageing and New Treatments

Skin is the largest body organ and is impacted during aging both by intrinsic aging (decline in mitochondrial function and…

EMJ

In Memory of John Mills, MBE

We fondly remember John Mills MBE, patient advocate who was dedicated to raising awareness and improving care for patients with vasculitis.

Cardiology under the microscope

This infographic explores the ins and outs of the cardiology market, including market size, top pharmaceutical and medical device players and the regional impact of cardiovascular disease.